相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A polyamidoamine (PAMAM) derivative dendrimer with high loading capacity of TLR7/8 agonist for improved cancer immunotherapy
Jia-Si Wu et al.
NANO RESEARCH (2022)
Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
Patricia Figueiredo et al.
ACTA BIOMATERIALIA (2021)
Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs
Gregory M. Cresswell et al.
CANCER RESEARCH (2021)
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Lipid in Chips: A Brief Review of Liposomes Formation by Microfluidics
Guo Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
Jutaek Nam et al.
ADVANCED SCIENCE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy
Mengying He et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Baharak Bahmani et al.
NATURE COMMUNICATIONS (2021)
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Advances in Bio-Based Polymers for Colorectal Cancer Treatment: Hydrogels and Nanoplatforms
Anna Maspes et al.
GELS (2021)
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells
Faezzah Baharom et al.
NATURE IMMUNOLOGY (2021)
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowl cancer
Ines Gockel et al.
TUMORI JOURNAL (2020)
Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination
Po-Ming Chen et al.
BIOMATERIALS (2020)
Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
Lindsay M. Scheetz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Gold Nanoparticles in Conjunction with Nucleic Acids as a Modern Molecular System for Cellular Delivery
Anna Graczyk et al.
MOLECULES (2020)
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
Geoffrey M. Lynn et al.
NATURE BIOTECHNOLOGY (2020)
Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
Sang Hoon Lee et al.
PHARMACEUTICS (2020)
A TLR4-TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells
Allison M. Dyevoich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Association of Th2 high tumors with aggressive features of breast cancer.
Yoshihisa Tokumaru et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy
Hyunjoon Kim et al.
MOLECULAR PHARMACEUTICS (2020)
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
Qianqian Ni et al.
SCIENCE ADVANCES (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
Permissive State of EMT: The Role of Immune Cell Compartment
Vita Fedele et al.
FRONTIERS IN ONCOLOGY (2020)
Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer
Milda Naciute et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers
Enas El-Maghawry et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Antigen Cross-Presentation by Macrophages
Elke M. Muntjewerff et al.
FRONTIERS IN IMMUNOLOGY (2020)
Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy
Chunyan Liu et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
A biodegradable thermosensitive hydrogel vaccine for cancer immunotherapy
Fan Yang et al.
APPLIED MATERIALS TODAY (2020)
Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy
Kaiyuan Ni et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Nanoparticles Presenting Potent TLR7/8 Agonists Enhance Anti-PD-L1 Immunotherapy in Cancer Treatment
Anton A. A. Smith et al.
BIOMACROMOLECULES (2020)
Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
Colin G. Buss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Biomimetic Polymer Magnetic Nanocarrier Polarizing Tumor-Associated Macrophages for Potentiating Immunotherapy
Lingqiao Liu et al.
SMALL (2020)
Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System
Nasrul Wathoni et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
Floriane Auderset et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth
Hui Shan et al.
NANOSCALE (2020)
Co-precipitation synthesis of stable iron oxide nanoparticles with NaOH: New insights and continuous production via flow chemistry
Maximilian O. Besenhard et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients
Signe Bremholm Ellebaek et al.
PLEURA AND PERITONEUM (2020)
Advances in immunotherapy for colorectal cancer: a review
Gol Golshani et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
Wim Ceelen et al.
TRENDS IN CANCER (2020)
Dendrimer nanoparticles for colorectal cancer applications
M. R. Carvalho et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics
Dipak Dilip Gadade et al.
ADVANCED PHARMACEUTICAL BULLETIN (2020)
Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity
Marcela A. Haro et al.
CANCER RESEARCH (2019)
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
Daisuke Muraoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A Tumor-Peptide-Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy
Carolin Hesse et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Targeting Delivery of Oligodeoxynucleotides to Macrophages by Mannosylated Cationic Albumin for Immune Stimulation in Cancer Treatment
Shu-Lun Ai et al.
MOLECULAR PHARMACEUTICS (2019)
The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis
Yamei Zhao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
Yanxian Feng et al.
NATURE COMMUNICATIONS (2019)
Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis
Molood Shariati et al.
CANCERS (2019)
Cytotoxicity of Dendrimers
Anna Janaszewska et al.
BIOMOLECULES (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Indocyanine green and poly I:C containing thermo-responsive liposomes used in immune-photothermal therapy prevent cancer growth and metastasis
Li Xu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
Lisa Munakata et al.
JOURNAL OF CONTROLLED RELEASE (2019)
The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T-Cell Repertoire
Shubhankar Nath et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2019)
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen et al.
ADVANCED MATERIALS (2019)
The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game
Yifan Zhan et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses
Fiamma Salerno et al.
JOURNAL OF IMMUNOLOGY (2019)
Recent clinical trends in Toll-like receptor targeting therapeutics
Muhammad Ayaz Anwar et al.
MEDICINAL RESEARCH REVIEWS (2019)
Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity
Kristopher K. Short et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
Candido G. Da Silva et al.
THERANOSTICS (2019)
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
NATURE REVIEWS CANCER (2019)
Nanoparticles in the clinic: An update
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)
Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior
Luca Digiacomo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
Sara Nikoofal-Sahlabadi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation
Jerome Widmer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors
Sanghee Kang et al.
MEDICINE (2018)
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells
Felix S. Lichtenegger et al.
FRONTIERS IN IMMUNOLOGY (2018)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Harnessing albumin as a carrier for cancer therapies
Ella N. Hoogenboezem et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Modified Fe3O4 Magnetic Nanoparticle Delivery of CpG Inhibits Tumor Growth and Spontaneous Pulmonary Metastases to Enhance Immunotherapy
Xueyan Zhang et al.
NANOSCALE RESEARCH LETTERS (2018)
Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy
Jianbo Jia et al.
FRONTIERS IN ONCOLOGY (2018)
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Kaitlin Graham et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
The application of nanotechnology in immune checkpoint blockade for cancer treatment
Huan Deng et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
Melody Smith et al.
ONCOIMMUNOLOGY (2018)
Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity
Lais Salomao Arias et al.
ANTIBIOTICS-BASEL (2018)
Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy
Hyunjoon Kim et al.
NANOSCALE (2018)
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
Jessica Roelands et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
Tyler J. Goodwin et al.
VACCINE (2017)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy
Yohei Takeda et al.
CELL REPORTS (2017)
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
Elisabeth Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
The novel Toll-like receptor 2 agonist sUP3 enhances antigen Presentation and T cell activation by Dendritic cells
Xueheng Guo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
Ranjna Madan-Lala et al.
SCIENTIFIC REPORTS (2017)
Patient characteristics after completion of recruitment from the phase 3 IMPALA study with lefitolimod in metastatic colorectal carcinoma
D. Cunningham et al.
ANNALS OF ONCOLOGY (2017)
A Dual Macrophage Targeting Nanovector for Delivery of Oligodeoxynucleotides To Overcome Cancer-Associated Immunosuppression
Xiao-Yan He et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38/JNK signalling
Lucia Fischetti et al.
CYTOKINE (2017)
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer
Jun Xu et al.
ACS NANO (2017)
Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis - Mission possible?
George R. Dakwar et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Rodrigo Dienstmann et al.
NATURE REVIEWS CANCER (2017)
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
Etienne Becht et al.
CLINICAL CANCER RESEARCH (2016)
The immune system and cancer evasion strategies: therapeutic concepts
S. Muenst et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells
Shu Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Insight to drug delivery aspects for colorectal cancer
Arvind Gulbake et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice
Gabriela Maria Wiedemann et al.
ONCOIMMUNOLOGY (2016)
TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
Thibaud Spinetti et al.
ONCOIMMUNOLOGY (2016)
Exploring versatile applications of cyclodextrins: an overview
Neha Sharma et al.
DRUG DELIVERY (2016)
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Rodney A. Rosalia et al.
BIOMATERIALS (2015)
Effect of TLR Agonists on the Differentiation and Function of Human Monocytic Myeloid-Derived Suppressor Cells
Jing Wang et al.
JOURNAL OF IMMUNOLOGY (2015)
Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model
Tao Yin et al.
MOLECULAR MEDICINE REPORTS (2015)
Nanoparticle biointerfacing by platelet membrane cloaking
Che-Ming J. Hu et al.
NATURE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk
Mingye Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
M. Biswaranjan Subudhi et al.
MATERIALS (2015)
The TLR7 agonist induces tumor regression both by promoting CD4+T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells
Chenchen Wang et al.
ONCOTARGET (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
Eleni Maria Varypataki et al.
AAPS JOURNAL (2015)
Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming
Marc Dalod et al.
EMBO JOURNAL (2014)
Preparation of immunostimulatory single-walled carbon nanotube/CpG DNA complexes and evaluation of their potential in cancer immunotherapy
Shuwen Zhou et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
Hans-Joachim Schmoll et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
The Yin and Yang of Toll-like receptors in cancer
J-P Pradere et al.
ONCOGENE (2014)
Trafficking of endosomal Toll-like receptors
Bettina L. Lee et al.
TRENDS IN CELL BIOLOGY (2014)
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy
Ting-Ting Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Current status of pharmacological treatment of colorectal cancer
Reyhan Akhtar et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2014)
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Abhishek D. Garg et al.
BIOFACTORS (2013)
Inhibition of TGF-β signaling in combination with TLR7 ligation re-programs a tumoricidal phenotype in tumor-associated macrophages
Jiao Peng et al.
CANCER LETTERS (2013)
Microfluidic devices for continuous production of pDNA/cationic liposome complexes for gene delivery and vaccine therapy
Tiago Albertini Balbino et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
Zhenghong Xu et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Role of TH17 cytokines in the control of colorectal cancer
Veronica De Simone et al.
ONCOIMMUNOLOGY (2013)
Cationic lipids activate intracellular signaling pathways
Caroline Lonez et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Phospholipid nanodisc engineering for drug delivery systems
Tatsuya Murakami
BIOTECHNOLOGY JOURNAL (2012)
The Effects of TLR Activation on T-Cell Development and Differentiation
Bo Jin et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Hailing Lu et al.
CLINICAL CANCER RESEARCH (2012)
Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer
Gareth Betts et al.
GUT (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles
Chao Wang et al.
BIOMATERIALS (2011)
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells
Luis J. Cruz et al.
BIOMATERIALS (2011)
Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis
Dana Briesemeister et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Tc-99m-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection
Blanca E. Ocampo-Garcia et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice
Jinlin Liu et al.
PLOS ONE (2011)
Polymer nanoparticles: Preparation techniques and size-control parameters
J. Prasad Rao et al.
PROGRESS IN POLYMER SCIENCE (2011)
The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
Abbi L Engel et al.
Expert Review of Clinical Pharmacology (2011)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes
Francesca Bellora et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Introduction to metallic nanoparticles
Vicky V. Mody et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2010)
Cancer and the tumor microenvironment: a review of an essential relationship
Flaubert Mbeunkui et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
Natural killer cell cytotoxicity: how do they pull the trigger?
Nicola J. Topham et al.
IMMUNOLOGY (2009)
TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
Vesna Pulko et al.
JOURNAL OF IMMUNOLOGY (2009)
Entrapment of Hydrophobic Drugs in Nanoparticle Monolayers with Efficient Release into Cancer Cells
Chae Kyu Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal while Th2 Cells Promote Tumor Growth
Sungyoul Hong et al.
CANCER RESEARCH (2008)
Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages
Jose Rafael Sierra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Th2-mediated anti-tumour immunity: friend or foe?
J. I. Ellyard et al.
TISSUE ANTIGENS (2007)
Cutting edge: TLR2 directly triggers Th1 effector functions
Takayuki Imanishi et al.
JOURNAL OF IMMUNOLOGY (2007)
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes
Hui Huang et al.
IMMUNOLOGY (2007)
Inhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complex
Yukari Kuramoto et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles
VV Sokolova et al.
BIOMATERIALS (2006)
The extraordinary ligand binding properties of human serum albumin
M Fasano et al.
IUBMB LIFE (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
C Foged et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection
C Guiducci et al.
CANCER RESEARCH (2005)
The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed
L Riol-Blanco et al.
JOURNAL OF IMMUNOLOGY (2005)
Cutting edge:: Activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma
V Redecke et al.
JOURNAL OF IMMUNOLOGY (2004)
Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling
MA West et al.
SCIENCE (2004)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Toll-like receptor ligands directly promote activated CD4+ T cell survival
AE Gelman et al.
JOURNAL OF IMMUNOLOGY (2004)
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
I Caramalho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
CD4(+)CD25(+) regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice
DM Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Albumin binding as a general strategy for improving the pharmacokinetics of proteins
MS Dennis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Interferon-α and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets
T Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
G Ferlazzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
